CERAVE
Google image searchProduct monograph
Active ingredients
homosalate, 10 %/W/W
meradimate, 5 %/W/W
octinoxate, 5 %/W/W
octocrylene, 2 %/W/W
zinc oxide, 6.3 %/W/W
DIN: 02410923
Dosage form(s): LOTION
Route(s) of administration: TOPICAL
Schedule: OTC
Company: CERAVE CANADA
Date: 23-MAR-2018
ATC:
- D02 — EMOLLIENTS AND PROTECTIVES (ATC, ATC/DDD, )
- D02B — PROTECTIVES AGAINST UV-RADIATION (ATC, ATC/DDD)
- D02BA — Protectives against UV-radiation for topical use (ATC, ATC/DDD)
- D02BA30 — COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION (ATC/DDD)
